Byun JY, Lee JE, Shim YB, Kim J, Lee SY, Shin BR, Yoon NR, Park MH, Lee EK. Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea. Adv Ther. 2022 Nov 20.
Son KH, Kwon SH, Na HJ, Baek Y, Kim I, Lee EK. Quantitative Benefit-Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis. Vaccines (Basel). 2022 Nov 27;10(12):2029.
Min S, Kwon SH, Lee YW, Lee JM, Bae EJ, Lee EK. Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea. Vaccines (Basel). 2023 May 15;11(5):984.
Lee JE, Kwon SH, Kwon S, Jung HI, Nam JH, Lee EK. Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer. JAMA Netw Open. 2023 Jul 3;6(7):e2324852.
Na H, Kwon SH, Son KH, Baek Y, Kim J, Lee EK. Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis. BioDrugs. 2023 Mar;37(2):205-218.
Lim, YC., Lee, EK. & Park, MH. Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study. Lipids Health Dis 22, 151 (2023).
Byun, J. Y., Han, S., Qdaisat, A., & Park, C. (2023). Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer. Expert opinion on drug safety, 1–9. Advance online publication.
Shim YB, Oh BC, Lee EK, Park MH. Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum. BMC Cancer. 2024 Feb 9;24(1):189.
Cho JY, Jang SC, Kang DW, Lee EK, Koh H, Yoon DH, Park MH. A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma. Front Oncol. 2024 Feb 1;14:1282323.
Min S, Kwon SH, Lee EK, Nam JH. Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation. J Infect Public Health. 2024 Mar;17(3):478-485
Byun JY, Lee JE, Shim YB, Kim J, Lee SY, Shin BR, Yoon NR, Park MH, Lee EK. Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea. Adv Ther. 2022 Nov 20.
논문 보기(doi): 10.1007/s12325-022-02358-0
Son KH, Kwon SH, Na HJ, Baek Y, Kim I, Lee EK. Quantitative Benefit-Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis. Vaccines (Basel). 2022 Nov 27;10(12):2029.
논문보기(doi): 10.3390/vaccines10122029
Min S, Kwon SH, Lee YW, Lee JM, Bae EJ, Lee EK. Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea. Vaccines (Basel). 2023 May 15;11(5):984.
논문 보기(doi): 10.3390/vaccines11050984
Lee JE, Kwon SH, Kwon S, Jung HI, Nam JH, Lee EK. Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer. JAMA Netw Open. 2023 Jul 3;6(7):e2324852.
논문보기(doi) : 10.1001/jamanetworkopen.2023.24852.
Na H, Kwon SH, Son KH, Baek Y, Kim J, Lee EK. Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis. BioDrugs. 2023 Mar;37(2):205-218.
논문 보기(doi) : 10.1007/s40259-023-00576-8
Lim, YC., Lee, EK. & Park, MH. Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study. Lipids Health Dis 22, 151 (2023).
논문보기(doi): https://doi.org/10.1186/s12944-023-01903-2
Byun, J. Y., Han, S., Qdaisat, A., & Park, C. (2023). Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer. Expert opinion on drug safety, 1–9. Advance online publication.
논문보기(doi): https://doi.org/10.1080/14740338.2023.2294924
Shim YB, Oh BC, Lee EK, Park MH. Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum. BMC Cancer. 2024 Feb 9;24(1):189.
논문보기(doi) : https://doi.org/10.1186/s12885-024-11971-x
Cho JY, Jang SC, Kang DW, Lee EK, Koh H, Yoon DH, Park MH. A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma. Front Oncol. 2024 Feb 1;14:1282323.
논문보기(doi) : https://doi.org/10.3389/fonc.2024.1282323
Min S, Kwon SH, Lee EK, Nam JH. Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation. J Infect Public Health. 2024 Mar;17(3):478-485
논문보기(doi) : https://doi.org/10.1016/j.jiph.2024.01.002